## **Core Concept**
The question targets the pharmacological management of chemotherapy-induced nausea and vomiting (CINV), a common side effect of cancer chemotherapy. Effective management of CINV is crucial for improving the quality of life of patients undergoing chemotherapy. Various classes of drugs are used to prevent and treat CINV.

## **Why the Correct Answer is Right**
Ondansetron is a **5-HT3 receptor antagonist**. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. **5-HT3 receptors** are found in the **chemoreceptor trigger zone** of the area postrema and in the gastrointestinal tract. By inhibiting these receptors, ondansetron effectively prevents and treats nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While some antihistamines and anticholinergics can have antiemetic effects, they are not the first-line treatment for chemotherapy-induced vomiting.
- **Option B:** This option might refer to a drug not directly related to the primary treatment of CINV or might be a distractor without a clear antiemetic effect in this context.
- **Option D:** This could refer to another class of drugs not primarily used for CINV, such as dopamine antagonists, which are less effective for this specific indication.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **5-HT3 antagonists** like ondansetron are among the most effective agents for preventing **acute CINV**. They are often used in combination with other antiemetics, such as NK1 receptor antagonists (e.g., aprepitant) and corticosteroids, for enhanced effect.

## **Correct Answer:** C. Ondansetron